1. Home
  2. EVAX

as 06-06-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Evaxion AS is in the field of oncology. It used the AI-Immunology platform.

Founded: 2008 Country:
Denmark
Denmark
Employees: N/A City: N/A
Market Cap: 10.8M IPO Year: 2021
Target Price: $10.00 AVG Volume (30 days): 134.8K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -6.01 EPS Growth: N/A
52 Week Low/High: $1.20 - $19.95 Next Earning Date: 05-27-2025
Revenue: $3,293,000 Revenue Growth: 2555.64%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

EVAX Daily Stock ML Predictions

Share on Social Networks: